Gemtuzumab Ozogamicin in Combination with Vorinostat and Azacitidine As Induction and Post-Remission Therapy in Older Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML): A Phase 1 Study Walter, R. B., Medeiros, B. C., Gardner, K. M., Estey, E. H. AMER SOC HEMATOLOGY. 2011: 670

View details for Web of Science ID 000299597102136